Showing results (31-40 of 57) with videos related to

Sort By:
Pageof 6
Journal of Neuroimmunology|October 1, 2020
Repeated administration of LPS exaggerates amphetamine-induced locomotor response and causes learning deficits in miceMaximilian Tufvesson-Alm, Sophie Imbeault, Xi-Cong Liu, et al.
Brain, Behavior, and Immunity|May 5, 2023
Immunological protein profiling of first-episode psychosis patients identifies CSF and blood biomarkers correlating with disease severityFeride Eren, Lilly Schwieler, Funda Orhan, et al.
The International Journal of Neuropsychopharmacology|September 18, 2008
Elevated levels of kynurenic acid change the dopaminergic response to amphetamine: implications for schizophreniaSara K Olsson, Alexandra S Andersson, Klas R Linderholm, et al.
Neuroscience and Biobehavioral Reviews|April 16, 2018
Bioenergetics and synaptic plasticity as potential targets for individualizing treatment for depressionJ Blair Price, Carrie Bronars, Sophie Erhardt, et al.
International Journal of Tryptophan Research : IJTR|October 8, 2014
Imbalanced kynurenine pathway in schizophreniaMagdalena E Kegel, Maria Bhat, Elisabeth Skogh, et al.
Journal of Neuroinflammation|March 2, 2016
Electroconvulsive therapy suppresses the neurotoxic branch of the kynurenine pathway in treatment-resistant depressed patientsLilly Schwieler, Martin Samuelsson, Mark A Frye, et al.
Medicine and Science in Sports and Exercise|June 10, 2024
Mood, Cognitive Function, and Plasma Kynurenine Metabolites Responses Following Severe Changes in Physical ActivitySigitas Kamandulis, Inga Lukonaitiene, Audrius Snieckus, et al.
European Archives of Psychiatry and Clinical Neuroscience|July 15, 2019
Twin study shows association between monocyte chemoattractant protein-1 and kynurenic acid in cerebrospinal fluidViktoria Johansson, Sophie Erhardt, Göran Engberg, et al.
Schizophrenia (Heidelberg, Germany)|June 14, 2025
Cardiovascular protein profiling in patients with first-episode psychosisAnna Malmqvist, Feride Eren, Lilly Schwieler, et al.
Journal of Psychiatry & Neuroscience : JPN|June 23, 2011
Kynurenine 3-monooxygenase polymorphisms: relevance for kynurenic acid synthesis in patients with schizophrenia and healthy controlsMaria Holtze, Peter Saetre, Göran Engberg, et al.
Pageof 6